Carl-von-Basedow-Klinikum Saalekreis gGmbH

At Carl-von-Basedow-Klinikum Saalekreis gGmbH in Merseburg, clinical research in nervous system diseases focuses on serious emergency conditions such as acute ischemic stroke and status epilepticus in older adults. These studies are designed to evaluate new treatment options and generate evidence for better care in time-critical neurological conditions.

• Testing a new therapy for acute ischemic stroke to assess safety and potential benefit
• Studying treatment effectiveness for established status epilepticus in people aged 65 and older

This work aims to improve outcomes in high-risk neurological emergencies through better treatment strategies and clinical evidence.

Clinical trials in neoplasms at this hospital are centered on difficult-to-treat cancers, especially advanced colorectal carcinoma. The research is evaluating whether adding a new supportive treatment approach can improve disease control and help patients whose cancer no longer responds well to standard therapy.

• Assessing treatment effectiveness in metastatic colorectal carcinoma
• Exploring a new combination approach to improve tumor control in chemotherapy-resistant disease

The Medizinische Klinik II contributes to studies that aim to refine cancer care for patients with advanced disease.

Research also includes polycythemia vera, a chronic blood disorder within the broader area of neoplasms. One study is focused on identifying patients at risk of hydroxyurea resistance or intolerance, using predictive factors to support more personalized treatment decisions.

• Evaluating hydroxyurea resistance in polycythemia vera
• Using predictive tools to improve treatment planning for patients starting regular therapy

This line of research reflects an effort to improve long-term management of a complex hematologic condition through earlier identification of treatment challenges.